CAXIX
Price
$21.55
Change
+$0.20 (+0.94%)
Updated
Jun 12 closing price
Net Assets
95.63M
DGEFX
Price
$14.99
Change
+$0.10 (+0.67%)
Updated
Jun 12 closing price
Net Assets
506.61M
Interact to see
Advertisement

CAXIX vs DGEFX

Header iconCAXIX vs DGEFX Comparison
Open Charts CAXIX vs DGEFXBanner chart's image
CAXIX vs DGEFX Comparison Chart in %
View a ticker or compare two or three
VS
CAXIX vs. DGEFX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAXIX is a Buy and DGEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DGEFX has more cash in the bank: 507M vs. CAXIX (95.6M). DGEFX pays higher dividends than CAXIX: DGEFX (1.85) vs CAXIX (1.11). CAXIX was incepted earlier than DGEFX: CAXIX (12 years) vs DGEFX (9 years). CAXIX (1.37) is less costly to investors than DGEFX (1.07). DGEFX is a more actively managed with annual turnover of: 62.00 vs. CAXIX (30.00). DGEFX has a lower initial minimum investment than CAXIX: DGEFX (0) vs CAXIX (2500). CAXIX annual gain was more profitable for investors over the last year : 14.49 vs. DGEFX (12.74). DGEFX return over 5 years is better than : 48.33 vs. CAXIX (35.15).
CAXIXDGEFXCAXIX / DGEFX
Total Expense Ratio0.970.94103%
Annual Report Gross Expense Ratio1.371.07128%
Fund Existence12 years9 years-
Gain YTD11.0829.747114%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets95.6M507M19%
Annual Yield % from dividends1.111.8560%
Returns for 1 year14.4912.74114%
Returns for 3 years39.1745.0587%
Returns for 5 years35.1548.3373%
Returns for 10 years108.86N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRB36.520.63
+1.76%
H&R Block
XEL79.220.95
+1.21%
Xcel Energy
MSEX52.940.48
+0.92%
Middlesex Water Company
BRN1.07N/A
+0.47%
Barnwell Industries
ARCT6.97N/A
N/A
Arcturus Therapeutics Holdings